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Synopsis 
Ypc1p and Ydc1p are alkaline ceramide hydrolases, which reside in the ER. Ypc1p can catalyze 
the reverse reaction, i.e. the condensation of free fatty acids with phytosphingosine or 
dihydrosphingosine and overexpression of YPC1 or YDC1 can provide enough ceramide 
synthesis as to rescue the viability of cells lacking the normal acyl-CoA-dependent ceramide 
synthases. To better understand the coexistence of acyl-CoA dependent ceramide synthases and 
ceramidases in the ER we investigated the membrane topology of Ypc1p by probing cysteine 
accessibility of natural and substituted cysteines with membrane non-permeating mass-tagged 
probes. The N- and C-terminal ends of Ypc1p are oriented towards the lumen and cytosol, 
respectively. Two of the 5 natural cysteines, Cys27 and Cys219, are essential for enzymatic 
activity and form a disulfide bridge. The data allow inferring that all amino acids of Ypc1p that 
are conserved in the pfam PF05875 ceramidase motif and the CREST superfamily are located in 
or near the ER lumen. Microsomal assays using a lysine-specific reagent show that the reverse 
ceramidase activity can only be blocked when the reagent has access to Ypc1p from the lumenal 
side. Overall the data suggest that the active site of Ypc1p resides at the lumenal side of the ER 
membrane.  
Introduction 
The mature sphingolipids of Saccharomyces cerevisiae, namely the inositolphosphorylceramides 
(IPCs), mannosyl-IPCs (MIPCs) and inositolphosphoryl-MIPCs (M(IP)2Cs) are major 
components of the yeast plasma membrane. Moreover, as in higher eukaryotes, the metabolic 
intermediates of sphingolipid metabolism have been advocated as signaling molecules in many 
cell biological phenomena and responses (for review see [1]).  
Ceramide is a central metabolic intermediate (Fig. 1), which can result from breakdown of IPCs 
by Isc1p [2] or can be synthesized from acyl-CoA and long chain bases (LCBs) by ceramide 
synthases consisting of Lag1p or Lac1p in complex with Lip1p [3-7](Fig. 1). Yeast Lag1p and 
Lac1p are functionally redundant but concomitant deletion of LAG1 and LAC1 causes a 
significant growth defect in the genetic background of W303 cells and is lethal in the YPK9 
background [3, 4, 8]. Insertion of glycosylation sites and factor Xa protease sites into Lag1p and 
Lac1p, the catalytically active subunits of the yeast ceramide synthase, generated a topological 
model comprising eight putative membrane-spanning domains, whereby the Lag motif, 
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potentially containing the active site, has most conserved residues embedded inside the 
membrane [9]. The two substrates of Lag1p and Lac1p are a very long chain fatty acid (VLCFA) 
coupled to Coenzyme A (CoA) and a LCB, either phytosphingosine (PHS) or 
dihydrosphingosine (DHS) [10]. VLCFA-CoA is generated at the cytosolic surface of the ER 
membrane [11], whereas endogenous and exogenous LCBs are generated at the cytosolic and 
lumenal surface of the ER membrane, respectively [9]. Based on these data it has been suggested 
that LCBs could access the ceramide synthase active site from both sides of the membrane, 
whereas VLCFA-CoAs access it from the cytosolic side. However, although likely, it is not yet 
proven that the resulting ceramide is released into the cytoplasmic leaflet of the ER membrane.  
Natural and spin-labeled ceramides could rapidly flip-flop in liquid ordered giant unilamellar 
vesicles [12, 13], whereby the relevance of data obtained with these highly artificial systems to 
natural membranes remains to be demonstrated. In particular, the flip rate of C26:0-containing 
ceramides, typical of yeast and presumed to be concentrated in rafts, i.e. in areas of the ER 
membrane where lipids are present in a liquid ordered state, has not been measured so far. 
Ypc1p and Ydc1p are two highly homologous alkaline ceramidases showing 54% identity over 
their entire length [14, 15](Fig. 1). They are predicted to have 7 membrane helices (TMs)(Fig. 
S1). Overexpression of YPC1 or YDC1 suppresses the lethality of the lag1 lac1 double 
mutation [5, 16] by allowing ceramide biosynthesis through the reverse ceramidase reaction, i.e. 
the condensation of fatty acids with PHS or DHS [14, 15]. Indeed, the reverse reaction catalyzed 
by Ypc1p can easily be demonstrated in vitro when microsomes or the purified enzyme are 
incubated with radiolabeled fatty acids and PHS or DHS [14, 15].  
The simultaneous presence of acyl-CoA-dependent ceramide synthases and alkaline ceramidases 
in the ER seems to potentially create a futile circle. Indeed, in wild type (wt) cells, the 
overexpression of Ypc1p and Ydc1p proteins was shown to significantly increase the levels of 
free LCBs and LCB-phosphates and to reduce the biosynthetic flow of long chain bases towards 
mature sphingolipids, whereas deletion of YPC1 caused a significant increase of mature 
sphingolipids as detected through metabolic labeling with [3H]palmitate or [3H]serine or through 
mass spectrometric quantification of LCBs [14, 17].  
The three alkaline ceramidases ACER1, ACER2 and ACER3 of humans are homologues of 
YPC1. ACER1 is only present in skin keratinocytes, while ACER3, showing the highest 
homology with YPC1, is specific for ceramides carrying unsaturated fatty acids, a kind which is 
not commonly present in human cells [18]. The ubiquitous ACER2 is localized in the Golgi [18, 
19] whereas the mammalian acyl-CoA dependent ceramide synthases are localized in the ER 
[20]. As ACER2 levels are subject to regulation and moderate overexpression of ACER2 
increases sphingosine-1-phosphate levels, the potential for a futile circle also exists in 
mammalian cells [19].  
Ypc1p possesses the pfam PF05875 ceramidase motif containing 7 predicted transmembrane 
helices (TMs). To date this gene family contains 374 members in 211 species ranging from 
bacteria to man. A recent bioinformatics study revealed some distant similarity between alkaline 
ceramidases, the PAQR family of receptors, the PER1 GPI remodelase family, and several other 
gene families with known and unknown functions, all possessing conserved [SxxxH], [D] and 
[HxxxH] motifs being located at defined positions at the ends of predicted TMs 2,3 and 7 [17, 
21]. The members of this so-called CREST superfamily may all be metal-binding hydrolases 
[21].  
Here we tried to further our understanding of sphingolipid homeostasis by determining the 
membrane topology of the conserved residues of Ypc1p. 
Experimental  
Yeast strains, media, reagents. Strains are listed in supplemental Table SI. Cells were grown at 
30 °C on rich medium (YPD [1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) glucose], 
supplemented with uracil and adenine) or synthetic complete media (YNB-yeast nitrogen base, 
U.S. BIOLOGICAL) containing 2% glucose (D) or galactose (Gal) as a carbon source [22]. 
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Radiolabeled palmitic acid ([3H]palmitate, 60 Ci/mmol) was obtained from ANAWA trading 
SA, phytosphingosine (PHS) from AVANTI POLAR, N-ethylmaleimide (NEM) from FLUKA. 
Vivaspin 2 ultrafiltration devices having a 10 kDa molecular weight cut off were from 
MILLIPORE. All other reagents used were from suppliers described before [23].  
Bioinformatics tools. Conserved amino acids and motifs in Ypc1p were obtained from 
http://pfam.sanger.ac.uk and http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml. 
http://blast.ncbi.nlm.nih.gov/Blast.cgi was used for protein Blast searches. Alignments were 
done using ClustalW at http://www.ebi.ac.uk/. Topology predictions were obtained from 
TOPCONS http://topcons.cbr.su.se/. Calculations of Gmi values for TMs were obtained from 
the G predictor at http://dgpred.cbr.su.se/ (full protein scan with length correction turned 
off, allowing TMs from 15 to 30 amino acids in length). 
Construction of strains and plasmids. Plasmids and PCR primers are listed in supplemental 
Tables SII and SIII. The YPK9 lag lac1 strain rescued by overexpression of YPC1
(2.YPC1) was constructed by amplifying the open reading frame of YPC1 by PCR using 
genomic DNA as a template and primers 872 and 873 (Table SIII). The PCR product was 
inserted into pGREG533 by homologous recombination [24] yielding plasmid pBF842 having 
YPC1 behind the GAL1 promoter, N-terminally tagged by a 7xHA tag. This plasmid was 
transfected into 2.LAC1 cells and the plasmid pBM150-LAC1 was shuffled out by plating 
cells on medium containing 5’-fluoroorotic acid (FOA). The resulting strain grows on 
YNBGal. PCR analysis confirmed that LAC1 was absent, indicating that the plasmid 
pBM150-LAC1 had been shuffled out successfully. In pBF842 the sequence linking the N-
terminal 7xHA tag and the YPC1 ORF contains two cysteines, which in some SCAMTM
experiments served as a lumenal control, but also complicated the interpretation of results. 
Therefore we replaced the 7xHA tag and this linker sequence in the empty pGREG533 by a 
cysteine-free His6-V5 tag. For this, the GAL1 promoter of pGREG533 was amplified with 
primers 1493 and 1496 resulting in a fragment containing, between a Sal1 and EcoR1 site, the 
GAL1 promoter followed by a cysteine free His6-V5 epitope. This fragment was used to 
replace the Sal1-EcoR1 fragment of the original pGREG533 vector that contains the GAL1
promoter, the linker and the 7xHA tag. This replacement yielded the (empty) pNAG3 plasmid 
containing the GAL1 promoter directly followed by the His6-V5 tag. Some YPC1 alleles in 
pGREG533 were transferred into pNAG3 by cutting with EcoR1-Xho1 and ligating the 
fragment into similarly digested pNAG3. Mutations of Ypc1p natural cysteines to Ala or Gly 
and replacement of natural amino acids by cysteine were done using the QuikChange site-
directed mutagenesis kit (STRATAGENE). All mutations and constructs were verified by 
sequencing at MICROSYNTH, Balgach, Switzerland.
Preparation of microsomes. Microsomes used for protease accessibility, SCAMTM assays and 
TNBS derivatization were generated from cells cultured in galactose at 30°C overnight to an 
A600 of 3 using needle disruption of spheroplasts as described before [23]. At the end, the 
microsomes were resuspended in small volumes of buffers A, B or C, depending on the 
experiment: For protease accessibility assays in buffer A (0.2 M sorbitol, 3 mM EDTA, 5 mM 
MgCl2, 0.1 M potassium phosphate, pH 7.4), for SCAMTM in buffer B (0.2 M sorbitol, 5 mM 
MgCl2, 0.1 M sodium phosphate, pH 7.2). For lysine derivatization using TNBS, the 
microsomes were resuspended in buffer C (0.2 M sorbitol, 3 mM EDTA, 5 mM MgCl2, 0.1 M 
sodium bicarbonate, pH 8.5). Protein concentrations were determined using the Bradford 
reagent.  
Protease protection experiments. The 2.YPC1 cells were grown in YNBGal to stationary 
phase and microsomes were prepared. Aliquots (100 g protein/sample) were treated with 
proteinase K in buffer A for 30 min at RT. Reactions were stopped by addition of 1x Roche 
complete EDTA-free protease inhibitor cocktail and Pefabloc, EGTA and PMSF to final 
concentrations of 20, 5 and 20 mM, respectively. After 10 min proteins were precipitated by 
TCA and processed for Western blotting. 
Gel electrophoresis and Western blotting. Samples were incubated for 60 min at RT in 
reducing Laemmli sample buffer and separated by SDS-PAGE. Proteins were transferred onto 
a PVDF membrane using as transfer buffer 25 mM Tris, 192 mM glycine, pH 8.3, 10% 
MeOH.
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Cysteine accessibility (SCAMTM) assays. Plasmid born, cysteine-mutated, epitope-tagged 
alleles of Ypc1p were expressed in yy strain (FBY1224) or yy containing FLAG-Gpi8p 
(FBY8224), Gpi8p being a better lumenal control than Kar2p [25]. Microsomes were 
analyzed using ubiquitin-EMCS (UBI-mal) and PEG-mal in presence or absence of 
detergents as recently described [26]. After incubation in presence of UBI-mal (0.1 mM) or 
PEG-mal (0.5 mM) for 30 min on ice water, 40 mM DTT was added. After 10 min on ice-
water the derivatization of target proteins was visualized by SDS-PAGE and Western blotting 
using anti-V5, anti-FLAG and anti-Kar2p antibodies for detection of, Ypc1p, Gpi8p and 
Kar2p, respectively. Alternatively, we performed SCAMTM assays using NEM adapting 
protocols described previously [27, 28]. For this, microsomes (100 g of protein) were 
incubated with NEM for 30 min on ice-water unless indicated otherwise. Thereafter, residual 
NEM was removed by washing the membranes twice in buffer B by sedimentation. 
Microsomes were then incubated on ice water with 1 mM PEG-mal, except for the negative 
controls or when indicated otherwise. After 10 min SDS (0.5% final) or dodecylmaltoside 
(DDM) were added, and the samples were further incubated with PEG-mal for another 25 
min, at RT in the case of samples containing SDS, at 0° C for the others. The samples were 
then quenched with DTT and processed for Western blotting as described above. 
Microsome preparation for reverse ceramidase assay. Microsomes were generated roughly as 
described previously [14]. In short, cells were grown overnight at 30°C in galactose to an A600
of 2. Microsomes were prepared by glass bead disruption of cells in buffer D (25mM Tris-
HCl, pH 7.4, 5 mM CaCl2) containing 1mM PMSF and 1x Roche complete protease inhibitor 
cocktail. After removal of cell wall debris by low speed centrifugation, microsomes were 
sedimented at 16’000 x g for 30 min and resuspended in buffer E (25 mM Tris-HCl, pH 8.0, 5 
mM CaCl2). Solubilization was done with 0.5% v/v Triton X-100 on ice for 60 min, the 
lysates were centrifuged at 16,000 x g for 30 min at 4°C and the supernatant was utilized for 
the assays. 
Reverse ceramidase assay. For in vitro assessment of the enzymatic activity of ypc1 alleles, 
we chose to measure reverse ceramidase activity, which can be assayed using commercially 
available and relatively water soluble substrates. We used the method described previously 
[14] with minor modifications: Assays using microsomes from 2.YPC1 contained 5 nmol 
PHS, 2 ZCi of [3H]palmitic acid (0.3 nmol total). Assays of microsomes from yy having 
different Ypc1p alleles contained 10 nmol PHS and 10 ZCi of [3H]palmitic acid (0.23 nmol 
total). These ingredients were dried under vacuum in a rotary evaporator and dried lipids were 
dissolved in buffer E by water bath sonication. Reactions were started by the addition of 
microsomes or microsomal detergent extract. 100 and 10 g of microsomal protein from 
2.YPC1 and yy.YPC1 cells, respectively, were used for an assay based on preliminary 
experiments (supplemental Fig. S2). Volumes were complemented to 200 Zl, and samples 
were incubated at 30°C for 120 min at 300 rpm on a tube shaker. The reactions were 
terminated by adding 780 l of chloroform/methanol [2:1 (v/v)]. Lipids were extracted, 
desalted and mild base treated as recently described [29]. Aliquots of each sample were 
applied to Silica gel 60 plates, which were developed by ascending TLC in 
CHCl3/CH3OH/25% ammonium hydroxide, 9:2:0.5. Radioactivity was visualized and 
quantified by two-dimensional radioscanning using a Berthold radioscanner. Radioactivity 
contained in N-[3H]palmitoyl-PHS was expressed as a percentage of total radioactivity in the 
TLC lane.  Means and standard deviations of all values obtained through 2 - 4 independent 
experiments done in duplicate were calculated. 
DTR analysis. Dual topology reporters (DTR) were added to the C-terminus of C-terminally 
truncated versions of YPC1 using homologous recombination and constructs were analyzed as 
described [26, 30]. 
Lysine derivatization with TNBS. Microsomes from 2.YPC1 (FBY8183) (100 g/sample) in 
buffer C were left on ice-water for 15 min and centrifuged at 16'000  g for 30 min at 4 °C. 
After a second wash, the microsomes were again resuspended in buffer C and incubated with 
or without Triton X-100 (0.1% v/v) for 15 min on ice-water. After addition of TNBS (0.2%, 
v/v) or buffer, tubes were further incubated on ice-water for 30 min. Thereafter TNBS was 
quenched by adding 50 mM Tris pH 8.8, 50 mM imidazole and 100 mM lysine. After 40 min, 
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TNBS treated membranes or lysates were either used for a reverse ceramidase assay as 
described above or treated with proteinase K (PK) for 30 min at 0°C. Thereafter, proteinase K 
was blocked with inhibitors and TCA precipitation and proteins processed for Western 
blotting as described above. 
Results 
Cysteines at positions 27 and 219 are required for reverse ceramidase activity
SCAMTM designates a variation of the SCAM (substituted cysteine accessibility method) 
adapted for determining transmembrane segment orientation of polytopic membrane proteins 
[31-34]. When polytopic membrane proteins of microsomes are studied by SCAMTM, the 
reaction of cysteines with an non-permeating reagent indicate that they are in contact with water 
and located at the cytosolic side. To reduce ambiguities, one ideally analyzes alleles, which have 
a single or only few cysteine residues and still preserve good functionality. Ypc1p contains 5 
cysteines. Removing the 35 and 74 amino acids from the N- or C-terminal end of Ypc1p, 
thereby removing Cys27 or Cys271, respectively, yielded non-functional ypc1 alleles that could 
not rescue YPK9 lag1 lac1 ypc1 ydc1 (4) cells (Fig. 2A). All of the 42 members of the 
pfam PF05875 ceramidase family conserve Cys219 of Ypc1p. Indeed, replacing Cys219 as well 
as replacing Cys27 of Ypc1p with Ala created non-functional alleles (Fig. 2B). On the other 
hand, replacement of the three remaining cysteines (Cys107, Cys115 and Cys271) created ypc1
alleles that still could rescue YPK9 4 cells. Microsomal reverse ceramidase activity assays 
using such alleles confirmed that only Cys27 and Cys219 are required for enzymatic activity 
(Fig. 2C). Treating microsomes with the Cys-specific, membrane-permeating alkylating agent 
N-ethylmaleimide (NEM) abolished the reverse ceramidase activity of wt Ypc1p, whereas the 
activity of an allele retaining only the two essential cysteines C27 and C219 was NEM resistant. 
This indicates that derivatization of one or several of the three non-essential cysteines interferes 
with the activity.  
The N-terminus of Ypc1p is in the ER lumen  
In the absence of detergent, microsomal HA-Ypc1p was quite resistant to proteinase K (Fig. 
3A), although treatment with very high concentrations of proteinase K led to the appearance of a 
degradation product of lower molecular weight (not shown). As N-terminal tags often are not 
folded into the protein core, these results suggested that the N-terminus of this fully functional 
allele resides in the ER lumen. To confirm this notion, we analyzed by SCAMTM a cysteine-free 
HA-Ypc1p version carrying two cysteines in the linker region between the N-terminal 7xHA tag 
and the Ypc1p sequence. For SCAMTM analysis we used a novel mass-tagged maleimide 
derivative consisting of ubiquitin coupled to the lysine/cysteine heterobifunctional crosslinker 
EMCS, dubbed UBI-mal [26, 34]. The two cysteines in the linker region of HA-Ypc1p were 
accessible to UBI-mal only in the presence of mild detergent but not in its absence (Fig. 3B, 
lanes 2 and 3). This result also supports the notion that the N-terminus of Ypc1p is ER lumenal. 
Cysteine 271 is the only accessible Cys in wild type Ypc1p 
SCAMTM analysis of microsomes containing His6-V5-tagged wt Ypc1p showed that amongst its 
5 cysteines only one reacts with UBI-mal in the absence of detergent (Fig. 4A, lane 2). This 
cysteine must be located in a cytosolic loop. In the presence of the mild detergent 
dodecylmaltoside (DDM), a second cysteine was also slightly derivatized. Similarly, the 
utilization of PEG5000-maleimide (PEG-mal) as a mass tag showed that no more than one 
cysteine of wt Ypc1p was readily accessible, whether or not DDM was added (Fig. 4A, lanes 6-
8). Addition of SDS revealed that a maximum of 3 out of the 5 cysteines of Ypc1p could be 
derivatized (Fig. 4A, lane 5). Kar2p, a soluble Hsp70 of the ER lumen has a single cysteine 
residue and served as a control. It showed that lumenal cysteines became accessible only in the 
presence of DDM or SDS, albeit not of digitonin (Fig. 4A, lower panel). As reported before, the 
single cysteine of Kar2p is poorly accessible in the native protein, but becomes more accessible 
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in presence of the denaturing detergent SDS (Fig. 4A, lanes 3, 5, 8)[25, 34]. We also used an 
alternative approach, which avoids the use of mild detergents as a means to remove the 
membrane barrier. For this, microsomes (containing the proteins in their native state) are 
exposed to the membrane-permeating NEM so that cysteines on both sides of the membrane are 
alkylated. One then removes residual NEM and adds a mass-tagged maleimide derivative (UBI-
mal or PEG-mal) in presence of the denaturating detergent SDS [27, 28]. Those cysteines that 
are not alkylated by NEM when the protein is in the native state, but which get derivatized by a 
mass-tagged maleimide after denaturation, are classified as “buried” in the native protein 
structure. Only those cysteines that, in the native structure, are accessible to both NEM and 
water will not score as buried, since the alkylation reaction of cysteines by NEM also requires 
the presence of water. As for wt Ypc1p, this alternative approach again showed that UBI-mal 
derivatized up to three cysteines in the presence of SDS but only a single cysteine in the absence 
of detergent (Fig. 4B, lanes 1, 2, 6). Pretreatment with 1 mM NEM readily abolished the 
reactivity of this latter cysteine (Fig. 4B, lane 3), but not of the two other cysteines (Fig. 4B, lane 
4). These two buried cysteines remained inaccessible also to higher concentrations of NEM (Fig. 
4B, lanes 5 and 8). Thus, the two SCAMTM approaches used in Fig. 4A and 4B gave the same 
result: Of the five cysteines of Ypc1p, one is in a cytosolic loop, two are buried and the last two 
are derivatized under no circumstance.
As expected, a non-functional, cysteine-free version of Ypc1p was derivatized neither by UBI-
mal nor by PEG-mal, and the presence of detergents also did not uncover any reactive residues 
(Fig. 4C). A ypc1 allele in which Gly replaced C271 could neither be derivatized in absence of 
mild detergent (DDM) nor in its presence (Fig. 4D, lanes 1 - 3). Denaturation with SDS however 
rendered up to two cysteines accessible (Fig. 4D, lane 4). The result argued that the one 
cytosolic cysteine of wt Ypc1p, which is accessible to UBI-mal or PEG-mal in the absence of 
any detergent (Fig. 4A, lanes 1, 2, 7) is Cys271. 
Cysteines 27 and 219 form a disulfide link 
Two cysteines remained inaccessible both in wt and the C271G allele even in presence of SDS 
(Fig. 2A, B and D) and we guessed that this maybe due to the formation of a disulfide bond 
between those two cysteines that are essential for function, Cys27 and Cys219. Indeed, a ypc1-
27-219 allele retaining only these two cysteines (CGGCG) could not be derivatized with PEG-
mal even after denaturation with SDS (Fig. 4E, lanes 1, 3, 5, 7). On the other hand, after prior 
reduction with dithiothreitol (DDT) these two cysteines became accessible (Fig. 4E, lanes 2, 4, 
6, 8). This strongly suggests that a disulfide bond links these two cysteines in Ypc1p-27-219 and 
also in wt Ypc1p and supports the notion that the N-terminus of Ypc1p is located in the ER 
lumen. Generally speaking, Cys 27 and Cys219 both are absolutely conserved in the 42 founding 
members of the pfam05875 motif (Fig. 9), suggesting that the disulfide bridge is conserved 
throughout the ceramidase family.
Topology of loops L1-2 and L2-3 of Ypc1p 
For further topological studies we decided to substitute individual residues in predicted cytosolic 
or lumenal loops (Fig. S1) with a cysteine in the Ypc1p allele retaining only the two disulfide 
linked cysteines, Cys27 and C219 (ypc1-27-219). For this we preferentially chose non-
conserved residues in regions, for which the secondary structure was predicted to be random 
coil. The functionality of the constructs was tested by introducing them into 4.LAG1, a lag1
lac1 ypc1 ydc1 strain, which dies when it looses the LAG1-containing URA3 plasmid 
pBM150-LAG1. As shown in supplemental Fig. S3, all substitutions created functional alleles, 
which rescued growth of 4 cells on FOA with the exception of the K67C and G235C alleles. 
(FOA kills cells retaining the covering pBM150-LAG1 plasmid). Moreover, the ypc1-27-91-219 
allele carrying the K91C mutation provided only limited growth to 4 cells. It should be noted 
that the rescue of 4 cells requires massive overexpression of YPC1 [5, 16], so that any 
reduction of the catalytic activity of an allele is expected to result in reduced growth of 4 cells.  
To determine the topology of loops between TM1 and TM2 (loop L1- 2) we analyzed 
microsomes from yy cells harboring a ypc1-27-65-219 or ypc1-27-67-219 allele using both 
approaches, opening membranes with mild detergent as in Fig. 4A or pretreating them with 
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NEM as in Fig. 4B. Cysteines in positions 65 and 67 are not directly accessible when 
microsomes are incubated with PEG-mal but become accessible in presence of mild detergent 
(Fig. 5B, lane 2 vs. 7; Fig. 5C, lane 2 vs. 12). Also, NEM is able to prevent their subsequent 
derivatization with PEG-mal, arguing that they are not buried but exposed at the ER lumenal 
side of the membrane (Fig. 5B, lane 4; Fig. 5C, lanes 3 - 10). As a control in most of the 
following SCAMTM experiments we used a FLAG-tagged Gpi8p allele. Gpi8p is the core 
protease of the 5-subunit GPI transamidase complex. It is a 50 kDa type I membrane 
glycoprotein having its N-terminus and all of its 4 Cys on the lumenal side of the ER membrane 
with only 14 amino acids being displayed at the cytosolic side of the membrane [35]. Up to 4 
cysteines were accessible to PEG-mal, when Gpi8p was denatured with SDS (at 25°C), up to 3 
when the membrane was permeabilized by DDM at 0°C (Fig. 5B and E, lanes 6 and 7). 
Pretreatment with NEM confirmed that only one cysteine of Gpi8p is buried inside the protein 
and cannot be reached by 10 mM NEM at 0°C, although at a higher temperature (25°C) even 
this cysteine becomes accessible to NEM (Fig. 5B and E, lanes 4 and 5). As these controls 
indicate that NEM efficiently penetrated into the ER lumen, the data obtained in Fig. 5B and C 
argue that L1-2 is lumenal. The same pattern, characteristic for lumenally exposed cysteines, 
was also observed for two cysteines introduced at positions 91 and 93 in loop L2-3, a very short 
loop comprising only amino acids 91 - 94 according to the current TOPCONS global prediction 
(Fig. 5A, E, F). This prediction also places T89 to the end of TM2 and indeed, we found the 
T89C cysteine of ypc1-27-89-219 allele to be buried, although it became partially accessible to 
NEM at 25°C (Fig. 5D, lanes 4 and 5). Overall, the data clearly indicate that loops L1-2 and L2-
3 are lumenal. 
Topology of loops L3-4, L4-5, L5-6 and L6-7 of Ypc1p 
Using the same approach as described above we found that cysteines replacing N123 and G124 
both were immediately accessible to PEG-mal, in the absence of any detergent (Fig. 6B and C). 
This results shows that L3-4 is cytosolic (Fig. 6A).  
Loop L4-5 is very short and comprises only amino acids 157 to 159 according to TOPCONS 
(Fig. 6A). It was probed by introducing cysteines at positions 157 and 158. These cysteines were 
not accessible in the absence of detergent, but accessible to NEM, arguing that they are 
lumenally exposed (Fig. 6D and E).  
Loop L5-6 comprises amino acids 181-195 according to TOPCONS and was probed by 
substituting cysteines at positions 181, 182, 184 and 185, all of which seemed to be located at 
the lumenal side of the ER (Fig. 7A-E). S197 residing at the beginning of the following TM6 
proved to be completely buried (Fig. 7F). Overall, the data indicate a lumenal orientation of L5-
6. 
Loop L6-7 comprises, according to TOPCONS, amino acids 217-245. The ypc1-27-219-235
allele is non-functional but SCAMTM indicates a lumenal position of 235 (Fig. 7G). The ypc1-
27-219-236 allele was classified as partially buried, since part of the protein could still be 
derivatized with PEG-mal after NEM treatment (Fig. 7H, lanes 4 and 6). Doing the NEM 
pretreatment at 25 instead of 0°C, or raising the NEM concentration to 20 mM did not increase 
the accessibility of Cys236 (Fig. 7H, lanes 4-6, 8, 9). Another way to look at the data is to say 
that the PEG-mal derivatization of Cys 236 was substantially reduced by NEM pretreatment , 
indicating that it is partially accessible to NEM (Fig. 7H, lanes 2, 4-6). Similarly Cys 236 was 
also partially accessible to PEG-mal in presence of DDM (Fig. 7H, lane 7), whereas it was not 
accessible to PEG-mal in the absence of detergent (Fig. 7H, lane 2). The result is compatible 
with the idea that there are two forms of Ypc1p, one in which Cys 236 is accessible from the 
lumenal side of the ER, another where this cysteine is buried, e.g. because another protein 
interacts with Ypc1p. The lumenal location of L6-7 (Fig. 7A) is supported also by a dual 
topology reporter (DTR) inserted after P233 showing that the Ypc1p-P233-DTR construct is 
glycosylated and does not support growth of his4 cells on histidinol (Fig. 7I). The DTR 
approach has been shown to be able to yield correct topology prediction only, when the DTR is 
inserted at a certain distance downstream of a TM having a negative Gmi and of sufficient 
length to span the membrane [34, 36]. These conditions are met for DTR cassettes truncating 
Ypc1p after TM6. The existence of a disulfide bond between C27 and C219 also supports a 
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lumenal orientation of L6-7 is (Fig. 4E).
The C-terminal end of Ypc1p is cytosolic 
The TOPCONS global prediction places amino acids 267- 316 into the cytosol. Indeed, a global 
study to locate the C-terminal ends of yeast membrane proteins using DTR has mapped the C-
terminal end of Ypc1p to the cytosol [37]. This conclusion is fully supported also by the results 
obtained with the Ypc1p-P292-DTR construct shown in Fig. 7I. It is further supported by 
SCAMTM data showing a cytosolic location of the natural Cys271 (Fig. 4), but also the SCAMTM
data shown in Fig. S4. When generating the ypc1-27-184-219 allele the PCR mutagenesis 
wrongly introduced an additional mutation, S293C. This ypc1-27-184-219-293 allele contains 
one cysteine, which reacts with PEG-mal in the absence of detergent (Fig. S4A, lane 2) whereas 
the corrected ypc127-184-219 does not react in this condition (Fig. 7D, lane 2). Thus, Cys293 
must be cytosolic. Similarly, probing an allele having an S297C mutation showed that position 
297 is accessible from the cytosolic side of the membrane (Fig. S4B). Overall, all data argue that 
the C-terminus of Ypc1p is cytosolic, allowing its C-terminal KKEK motif to act as an ER 
retrieval signal. 
Lysine derivatization in the absence of detergent does not interfere with Ypc1p activity 
Trinitrobenzene sulfonic acid (TNBS) is a lysine-reactive reagent, which does not penetrate 
the membrane. When TNBS was added to intact microsomes, the reverse ceramidase activity 
remained unchanged (Fig. 8A and B, lanes 1 and 3). The addition of TNBS to an assay 
containing Triton X-100 however caused a drastic reduction of Ypc1p activity (Fig. 8A and 
B, lanes 2 and 4). When, before being added to microsomes, TNBS was quenched with a mix 
of lysine, imidazol and Tris, it did not inhibit reverse ceramidase activity (Fig. 8A, lanes 3, 4, 
6, 7). This activity did not decrease even when microsomes were treated with TNBS for up to 
two hours (not shown). TNBS-derivatized proteins were detected by Western blotting using 
anti-DNP antibody (Fig. S5A). To localize the TNBS-derivatization on microsomal proteins, 
TNBS-treated microsomes were treated with proteinase K. When derivatization was 
performed in presence of Triton X-100, all proteins were almost completely digested by 
subsequent addition of proteinase K (Fig. S5A, B, C, lanes 3, 6 - 7). Even when TNBS 
derivatization was done in the absence of detergent, a large part of the TNBS-derivatized 
proteins were destroyed by proteinase K (Fig. S5A, lanes 2, 4 - 5), whereas 74% of the ER 
lumenal Kar2p and 80% of the lumenally tagged HA-Ypc1p were preserved (Fig. S5B, C).  
This indicates that TNBS does not efficiently penetrate the ER membrane. The resistance of 
Kar2p and HA-Ypc1p to protease added from the cytosolic side is not due to the protection of 
lysines by TNBS, since these proteins were even more resistant when TNBS treatment was 
omitted (Fig. S5A – C, lanes 4, 5, 8 – 11). Incidentally, the results documented again that 
Ypc1p is highly resistant to protease added from the cytosolic side of microsomes, whereas it 
is readily degraded when detergent is present (Figs. 3A, 9E). Ypc1p contains 16 lysine 
residues, 9 of which are in cytosolic loops, while the other 7 are in lumenal loops, according 
to our model (Fig. 9). The data argue that the derivatization of cytosolic lysines in the absence 
of detergent does not interfere with reverse ceramidase activity, whereas derivatization of 
some lysine in the presence of detergent does, although no single lysine of Ypc1p is 
conserved.  
Discussion 
Ceramides are appearing as intermediates in both biosynthetic and catabolic pathways insuring 
subcellular and global sphingolipid and lipid homeostasis of eukaryotic cells. In yeast, ceramides 
are generated either through the acyl-CoA dependent ceramide synthases Lag1p and Lac1p or 
through degradation of IPCs. Isc1p most certainly generates ceramides from IPCs in the 
cytosolic leaflet while this is not proven for the ceramide synthases Lag1p and Lac1p. 
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Ceramides basically can enter four different pathways (Fig. 1): i) IPC biosynthesis [38], ii) GPI 
anchor remodeling [39], iii)1-O-acylation generating acylceramides [29], and iv) hydrolysis by 
ceramidases [14] (Fig. 1). Pathways i-iii have been claimed to occur at the lumenal side of the 
secretory pathway based on biochemical data and bioinformatic analysis of the location of 
conserved motifs [27, 29, 40-43]. This report makes it likely that also the degradation via 
alkaline ceramidases occurs lumenally. Thus, the ER based anabolic pathways leading to 
integration of ceramides into GPI anchors and acylceramides may compete with ceramidases for 
ceramides residing in the same leaflet of the bilayer.  
A previous study showed that the human alkaline ceramidase ACER2 has the N-terminal end 
in the lumen, the C-terminus in the cytosol and that the deletion of the N-terminal end, 
containing residues conserved between yeast and mammalian alkaline ceramidases, abolishes 
ceramidase activity [19]. The bioinformatic predictions of the membrane topology of ACER2 
place the most highly conversed residues of all alkaline ceramidases into the lumen, whereas 
the C terminus and three putative cytosolic loops do not contain highly conserved residues. 
Based on this it was proposed that the presumed active site of ACER2 may be located in the 
lumen of the Golgi complex [19]. Based on bioinformatics tools, this prediction can be 
extrapolated to the other two human ceramidases [21](Fig. S6). Overall, almost all residues 
conserved between YPC1 and its closest fungal as well as metazoan homologues are in or 
near the ER lumen, according to both, our topology model as well as the global TOPCONS 
prediction (Fig. S1). Interestingly, part of the residues conserved in the PF05875 ceramidase 
family are also conserved in the larger CREST superfamily encompassing about 3000 
predicted proteins with 7 transmembrane helices (Fig. 9, Fig. S1). Yeast harbors four other 
proteins belonging to the CREST superfamily, namely the Izh1-Izh4 proteins, three of which 
have been localized in the ER [44]. Within the CREST superfamily, Izh1-Izh4 proteins are 
most closely related to the PAQR family, a family that is predicted to have an inverted 
topology in that all 5 conserved residues are predicted to be cytosolic [21]. The global 
TOPCONS predictions for Izh1p-Izh4p indeed predict a cytosolic location of conserved 
residues (Fig. S6), and these predictions have an uncommonly high reliability, since for each 
Izh protein, all 5 algorithms (corresponding to lines a –e of Fig. S1) indicate the exact same 
topology (not shown). Interestingly, Izh2p has been shown to be involved in a signaling 
pathway, which results in the elevation of LCBs, raising the possibility that also this group of 
proteins acts as ceramidases [17]. If this can be shown biochemically, it would imply that 
functionally and structurally similar yeast proteins are made with two opposite topologies.  
While mammalian ceramidase ACER2 has been shown to have the potential of regulating N-
glycan modifications and production of sphingosine and sphingosine-1-phosphates in studies 
where the proteins was overexpressed [19, 45], the reasons for the preservation of alkaline 
ceramidases in fungi so far is not apparent and further efforts are required to understand their 
physiological roles. 
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Figure legends 
Fig. 1. Ceramide biosynthesis and utilization in yeast. A, The various metabolic pathways 
generating and consuming ceramides are shown. Gene names are in italic. B, TOPCONS is one 
of the most recent bioinformatic tools for the prediction of TMs [46]. Lines a - e show the 
topologies predicted for Ypc1p by the 5 TOPCONS algorithms SCAMPI-seq, SCAMPI-msa, 
PRODIV, PRO and OCTOPUS. The TOPCONS global prediction (line f) takes into account two 
further algorithms (Gmi and ZPRED) and differs slightly from the topology proposed by the 
present report (line g). Potential TMs are numbered 1-7 above line a, their theoretical Gmi
values (kcal/mol) obtained from the G predictor are indicated below line g. Sequences 
predicted to be lumenal and cytosolic are in blue and red, respectively.  
Fig. 2. Cysteines at positions 27 and 219 are required for reverse ceramidase activity. A,
the YPK9 4.LAG1 (FBY2171) strain was transfected with wt YPC1 or ypc1 alleles having N- 
or C-terminal truncations up to the indicated amino acids. Ten fold dilutions of cells were plated 
onto YNBGal with or without 5’-fluoroorotic acid (FOA). On FOA, only cells having lost the 
pBM150-LAG1 (URA3) plasmid can survive. Plates were incubated for 3 days at 30°C. B, the 
same strain was transfected with ypc1 alleles in which part of the five natural cysteines were 
replaced by Ala or Gly. Their exact positions are indicated at the top with positions containing 
conserved cysteines being in red. Functionality of the alleles was tested as in panel A. C, some 
alleles tested in panel B were transfected into yy strain (FBY1224) and microsomes were 
used for an in vitro microsomal reverse ceramidase assay. Samples were run out on TLC, 
radioactivity was detected by radioscanning and N-[3H]palmitoyl-PHS expressed as % of total 
counts per lane. Means of two independent assays done in duplicate are shown with standard 
deviations. D, 100 g of microsomes from yy cells harboring the wt CCCCC (FBY8203) or 
the CGGCG allele (FBY8204) of YPC1 were incubated with 15 mM NEM or ethanol for control 
during 30 min on ice-water. Microsomes were sedimented (16’000 g x 30 min) at 4°C. The 
pellet was resuspended in 200 l of buffer E containing 20 mM DTT and further incubated for 
10 min on ice-water. Ten g/sample were used for Ypc1p reverse activity assays. Data were 
analyzed as in panel C, means of 3 independent assays done in duplicates were plotted.  
Fig. 3. The N terminus of Ypc1p is in the lumen of the ER. A, microsomes from 2.YPC1 
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cells containing HA-Ypc1p with a 7xHA tag at the N-terminus were incubated without or with 
the indicated amounts of proteinase K (PK) in the presence or absence of Triton X-100 (0.5%, 
v/v) for 30 min at room temperature (RT) and products were analyzed by Western blotting using 
anti-HA and anti-Kar2p antibodies. B, microsomes from yy cells harboring pBF849 were 
used. pBF849 carries a cysteine-free (AGGAG) HA-Ypc1p allele with two non-natural cysteines 
residing in the linker between the 7xHA tag and YPC1. These non-natural cysteines were 
localized by SCAMTM incubating samples with UBI-mal, in presence of 0.66% DDM (D), 
0.16% SDS. 
Fig. 4. Cysteines 27 and 219 of Ypc1p are forming an S-S bridge. A, microsomes from yy
cells transfected with wt His6-V5-YPC1 were treated with UBI-mal or PEG-mal in presence of 
buffer (-), digitonin (Dt, 0.66%), DDM (D, 0.66%) or SDS (S, 0.16%). In B, the same 
microsomes were pretreated with 1, 5 or 10 mM NEM at 0°C and then washed twice before 
being treated with UBI-mal (0.1 mM) in the presence or absence of SDS (S, 0.5%). C and D, as 
panel A but using microsomes containing the cysteine-free His6-V5-Ypc1p (C) or a His6-V5-
Ypc1p lacking C271 (D). E, microsomes from yy cells having His6-V5-Ypc1p-27-219 
(pBF85) were solubilized in 0.5% SDS in the presence and absence of DTT (25 mM) for 60 min 
at RT. Upon removal of DTT by ultrafiltration the lysates were treated with 0, 1, 3 or 5 mM 
PEG-mal. The protein extracts were processed as above.  
Fig. 5. Topology of loops L1-2 and L2-3. A, TM predictions for the first 130 amino acids of 
Ypc1p by the TOPCONS global prediction (line f) and the one proposed by the present report 
(line g) as described in Fig. S1. Positions of amino acid residues replaced by cysteines are 
marked in green. B-F, microsomes from FBY8228 (B), FBY8229 (C), FBY8263 (D), FBY8230 
(E) and FBY8231 (F) were incubated for 30 min with 0 - 20 mM NEM at indicated temperature 
(°C) and processed for SCAMTM.
Fig. 6. Topology of loops L3-4 and L4-5. A, TM predictions for amino acids 90-180 of Ypc1p 
as in Fig. 5A. B-E, microsomes from FBY8233 (B), FBY8234 (C), FBY8264 (D) and FBY8235 
(E) cells were incubated for 30 min with 0 or 10 mM NEM at 0°C and processed for SCAMTM.
Fig. 7. Topology of loops L5-6 and L6-7. A, TM predictions for amino acids 160-270 of Ypc1p 
as in Fig. 5A. B-H, microsomes from FBY8236 (B), FBY8237 (C), FBY8238 (D), FBY8239 
(E), FBY8240 (F), FBY8241 (G) and FBY8242 (H) cells were incubated for 30 min with 0 - 20 
mM NEM at indicated temperatures and processed for SCAMTM. I, DTR constructs containing 
amino acids 1 to 233 or 292 of Ypc1p followed by the DTR (3xHA-Suc2-His4C cassette) were 
transfected into his4 (STY50) cells. Left panel, serial ten fold dilutions of cells were plated on 
minimal medium containing either histidine or its precursor, histidinol. (His4 grow on 
histidinol, if the DTR cassette is on the cytosolic side of the ER membrane, not if it is lumenal.) 
Right panel, proteins of exponentially growing cells were extracted, incubated with (+) or 
without (-) endoglycosidase H, separated by SDS-PAGE and processed for Western blotting 
using anti-HA antibody. 
Fig. 8. Ypc1p activity is blocked by TNBS in the presence of detergent. A, microsomes from 
2.YPC1 were incubated with or without TNBS (0.2%, v/v) in the presence or absence of Triton 
X-100 (0.1% v/v) on ice-water. Thereafter TNBS was quenched and ingredients for the reverse 
ceramidase assay were added. Microsomes in lane 5 were boiled. In lanes 6 and 7 TNBS had 
been quenched before being added to microsomes. The Berthold radioscans is shown. B,
quantification of [3H]C16 incorporated into N-[3H]palmitoyl-PHS (Cer) in lanes 1 – 4 of panel 
A, as % of total counts per lane, and of three independent repeat assays each done in duplicates. 
Fig. 9. Topology model for Ypc1p based on this study. Membrane is bluish, the 24 residues 
considered to be highly conserved in pfam motif PF05875 at Sanger are in red lettering, the 13 
residues strictly conserved in the same PF05875 according to NCBI are in red circles, the 5 
residues conserved in the CREST family are underlaid in turquoise, the residues which were 

ht
tp
://
do
c.
re
ro
.c
h
substituted for SCAM are underlaid yellow if the cysteine substitution resulted in a fully 
functional allele, violet, when substitution compromised the functionality. Non-conserved 
cysteines are in blue lettering and residues where a DTR was inserted are underlaid green. 
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